François Panet

Inflammatory response to the anti PD-L1 drug, atezolizumab, masquerades as breast implant rupture

E. Croteau, M. Richard, M. Pavic, 2019, European Journal of Nuclear Medicine and Molecular Imaging.

The risks associated with the widespread use of telemedicine in oncology: Four cases and review of the literature

K. Sultanem, D. Melnychuk, V. Morin, 2021, Cancer reports.

Sustained Response to the Mitogen-Activated Extracellular Kinase Inhibitor Trametinib in a Spindle Cell Sarcoma Harboring a QKI-RAF1 Gene Fusion

T. Alcindor, Sungmin Jung, François Panet, 2022, JCO precision oncology.

PACE4 is an important driver of ZR-75-1 estrogen receptor-positive breast cancer proliferation and tumor progression.

B. Guérin, R. Day, A. Kwiatkowska, 2017, European journal of cell biology.

Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases

S. Hofer, R. Soffietti, A. Seidman, 2023, Breast.

Predictors of nodal metastases in early stage HER2+ breast cancer: Deciding on treatment approach with neoadjuvant chemotherapy vs. upfront surgery.

M. Basik, S. Meterissian, I. Prakash, 2023, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.